Skip to main content

NSCLC clinical trials at UCSD
1 in progress, 0 open to new patients

  • Phase 1b Open-Label Study of PEGPH20 With Pembrolizumab

    Sorry, in progress, not accepting new patients

    This is a phase 1b study evaluating a combination of PEGPH20 and pembrolizumab in hyaluronan-high (HA-high) subjects with relapsed/refractory Non-Small Cell Lung Cancer (NSCLC) and HA-high subjects with relapsed/refractory gastric adenocarcinoma.

    La Jolla, California and other locations